Insights Into Neuroendocrine Tumors (NET)

Perspectives of community physicians from across the US on current treatment practices in and understanding of unresectable or advanced pancreatic NETs (PNETs), gastrointestinal extrapancreatic NETs (GEP-NETs), and lung NETs

West – September 30, 2024
Purchase Report

Faculty Chair

Heloisa Soares, MD, PhD

University of Utah Health, Salt Lake City, UT, USA

East – October 22, 2024
Purchase Report

Faculty Chair

Diane Reidy-Lagunes, MD

Memorial Sloan Kettering Cancer Center

More Information

  • Virtual
  • Arizona, California, Colorado, Nevada, Washington

More Information

  • Virtual
  • Florida, Illinois, Maryland, Michigan, North Carolina, New Jersey, New York, Ohio, Pennsylvania, Texas,

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A moderated roundtable discussion focusing on current treatment practices in and understanding of unresectable or advanced PNETs, GEP-NETs, and lung NETs
  • Disease state and data presentations were developed in conjunction with a national or regional oncology expert

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprised 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.